Paper

De novo design of phosphotyrosine peptide binders

Klupt, Kody A, Vafeados, Dionne K, Zhang, Jason Z, Herrmann, Luca C, Joyce, Emily, Brent, Rafael I, Bauer, Magnus S, Stewart, Lance, Kalvet, Indrek, Sturmfels, Pascal, Lu, Andrew, Coventry, Brian, Tischer, Doug, Krishna, Rohith, Baker, David, DiMaio, Frank, Motmaen, Amir, Shi, Jiuhan, Zhu, Siyu, Yim, Jason, Kang, Alex, Roullier, Nicole, Bera, Asim K, Silvestri, Isabella M, Moller, Carolina, Altae-Tran, Han, Li, Xinting, Juergens, David, Skotheim, Rebecca K, Ahern, Woody, Wu, Kejia, Lee, Gyu Rie, Mudumbi, Krishna C

2026

Overview

Phosphorylation on tyrosine is a key step in many signaling pathways. Despite recent progress in de novo design of protein binders, there are no current methods for designing binders that recognize phosphorylated proteins and peptides; this is a challenging problem as phosphate groups are highly charged, and phosphorylation often occurs within unstructured regions. Here we introduce RoseTTAFold Diffusion 2 for Molecular Interfaces (RFD2-MI), a deep generative framework for the design of binders for protein, ligand, and covalently modified protein targets. We demonstrate the power and versatility of this method by designing binders for four critical phosphotyrosine sites on three clinically relevant targets: Cluster of Differentiation 3 (CD3ε), Epidermal Growth Factor Receptor (EGFR), Insulin Receptor (INSR) and Signal Transducer and Activator of Transcription 5 (STAT5). Experimental characterization shows that the designs bind their phosphotyrosine containing targets with affinities comparable to native binding sites and have negligible binding to non-phosphorylated targets or phosphopeptides with different sequences. X-ray crystal structures of generated binders to CD3ε and EGFR are very close to the design models, demonstrating the accuracy of the design approach. A designed binder to an EGFR intracellular region phosphorylated upon EGF activation co-localizes with the receptor following EGF stimulation in single-particle tracking (SPT) experiments, demonstrating pY specific recognition in living cells. RFD2-MI provides a generalizable all-atom diffusion framework for probing and modulating phosphorylation-dependent signaling, and more generally, for developing research tools and targeted therapeutics against post-translationally modified proteins.

• Publisher: Cold Spring Harbor Laboratory
• Subject: Biochemistry